A RNA nanotechnology platform for a simultaneous two-in-one siRNA delivery and its application in synergistic RNAi therapy

被引:27
作者
Jang, Mihue [1 ]
Han, Hee Dong [2 ]
Ahn, Hyung Jun [1 ]
机构
[1] Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Seoul, South Korea
[2] Konkuk Univ, Sch Med, Dept Immunol, Chungju, South Korea
关键词
MESOPOROUS SILICA NANOPARTICLES; ANTIAPOPTOTIC CELLULAR DEFENSE; OVERCOME DRUG-RESISTANCE; SINGLE-STRANDED RNA; MULTIDRUG-RESISTANCE; CO-DELIVERY; IN-VITRO; CANCER-CELLS; DOXORUBICIN; RECOGNITION;
D O I
10.1038/srep32363
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Incorporating multiple copies of two RNAi molecules into a single nanostructure in a precisely controlled manner can provide an efficient delivery tool to regulate multiple gene pathways in the relation of mutual dependence. Here, we show a RNA nanotechnology platform for a two-in-one RNAi delivery system to contain polymeric two RNAi molecules within the same RNA nanoparticles, without the aid of polyelectrolyte condensation reagents. As our RNA nanoparticles lead to the simultaneous silencing of two targeted mRNAs, of which biological functions are highly interdependent, combination therapy for multi-drug resistance cancer cells, which was studied as a specific application of our two-inone RNAi delivery system, demonstrates the efficient synergistic effects for cancer therapy. Therefore, this RNA nanoparticles approach has an efficient tool for a simultaneous co-delivery of RNAi molecules in the RNAi-based biomedical applications, and our current studies present an efficient strategy to overcome multi-drug resistance caused by malfunction of genes in chemotherapy.
引用
收藏
页数:16
相关论文
共 51 条
[1]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[2]  
Birner P, 2001, CLIN CANCER RES, V7, P1669
[3]   A family of drug transporters: The multidrug resistance-associated proteins [J].
Borst, P ;
Evers, R ;
Kool, M ;
Wijnholds, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1295-1302
[4]   The Origin of Cholesterol's Condensing Effect [J].
Daly, Trevor A. ;
Wang, Minghui ;
Regen, Steven L. .
LANGMUIR, 2011, 27 (06) :2159-2161
[5]   The human ATP-binding cassette (ABC) transporter superfamily [J].
Dean, M ;
Rzhetsky, A ;
Allikmets, R .
GENOME RESEARCH, 2001, 11 (07) :1156-1166
[6]   Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA [J].
Diebold, SS ;
Kaisho, T ;
Hemmi, H ;
Akira, S ;
Sousa, CRE .
SCIENCE, 2004, 303 (5663) :1529-1531
[7]   Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells [J].
Donmez, Yaprak ;
Akhmetova, Laila ;
Iseri, Ozlem Darcansoy ;
Kars, Meltem Demirel ;
Gunduz, Ufuk .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (04) :823-828
[8]   A multidrug resistance transporter from human MCF-7 breast cancer cells [J].
Doyle, LA ;
Yang, WD ;
Abruzzo, LV ;
Krogmann, T ;
Gao, YM ;
Rishi, AK ;
Ross, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15665-15670
[9]   Cytokines as biomarkers of nanoparticle immunotoxicity [J].
Elsabahy, Mahmoud ;
Wooley, Karen L. .
CHEMICAL SOCIETY REVIEWS, 2013, 42 (12) :5552-5576
[10]   The P-glycoprotein multidrug transporter [J].
Fardel, O ;
Lecureur, V ;
Guillouzo, A .
GENERAL PHARMACOLOGY, 1996, 27 (08) :1283-1291